Anti-ARS antibodies carried a 14-fold increased risk of ILD, which escalated to 38-fold in cases of dual positivity for anti-ARS and anti-Ro-52 antibodies. The gene discussed is TRIM21; the disease is Axenfeld-Rieger syndrome.